TrialEuropean urology2021

Curative-intent Metastasis-directed Therapies for Molecularly-defined Oligorecurrent Prostate Cancer: A Prospective Phase II Trial Testing the Oligometastasis Hypothesis.

Rachel M Glicksman et al.PubMed ↗Publisher ↗

No numbers read from the abstract.